Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH

NAActive, not recruitingINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

February 18, 2018

Primary Completion Date

June 18, 2023

Study Completion Date

April 25, 2025

Conditions
BPH
Interventions
DEVICE

iTind

device implanted for 5-7 days

Trial Locations (12)

Unknown

Sydney Adventist Hospital Clinical School of the University of Sydney, Sydney

Hospital Center University De Bordeaux, Bordeaux

Hôpital Cochin, Paris

Hôpital Privé des Côtes d'Armor, Plérin

University Hospital Frankfurt, Frankfurt

Medical center - University of Freiburg, Freiburg im Breisgau

AOU di Catanzaro, Catanzaro

Azienda Ospedaliera Universitaria San Martino, Genova

San'Andrea Hospital, Rome

San Orbessano, Turin

Cantonal Hospital St. Gallen, Sankt Gallen

42 28035

Clínica CEMTRO Ventisquero la Condesa, Madrid

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medi-Tate Ltd.

INDUSTRY

NCT03395522 - Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH | Biotech Hunter | Biotech Hunter